1. Home
  2. Directory
  3. Pennsylvania
  4. Mechanicsburg
  5. Nurse Practitioner
  6. NPI Profile
  7. Prescriptions 1003249079

MS. AMANDA ELIZABETH HERSHEY CRNP
Prescription History 1003249079
Nurse Practitioner - Psychiatric/Mental Health in Mechanicsburg, PA


Quality Rating: 82.54 out of 100 score

NPI Status: Active since August 14, 2013

Contact Information

2005 TECHNOLOGY PKWY
SUITE 440
MECHANICSBURG, PA
ZIP 17050
Phone: (717) 791-2540
Fax: (717) 791-2549

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for MS. AMANDA ELIZABETH HERSHEY CRNP, an active Psychiatric/Mental Health specialist practicing in Mechanicsburg, PA. Our medical registry currently tracks 5 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 85 documented patient claims. Among these therapy options, the most frequently utilized medication is Lantus Solostar, which accounts for 28 claims alone.

Medication Index

Glipizide

Generic Formulation: GlipizideSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 15
30-Day Fills 16.0
Days Supply 470
PA State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills76.4
Peer Average Days Supply2,244
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 57.1% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $79.04 across this reporting matrix range.

Provider Avg Cost Per Claim

$5.27

State Avg Cost Per Claim

$10.02

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.

Therapeutic Applications

Glipizide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. It may also be used with other diabetes medications. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Glipizide belongs to the class of drugs known as sulfonylureas. It lowers blood sugar by causing the release of your body's natural insulin.

Hydrocortisone

Generic Formulation: HydrocortisoneSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 11
30-Day Fills 13.0
Days Supply 324
PA State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills34.2
Peer Average Days Supply800
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 60.7% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $285.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.96

State Avg Cost Per Claim

$22.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions.

Therapeutic Applications

Hydrocortisone is a man-made version of a natural substance (cortisol) made by the adrenal gland. This drug is used to treat low cortisol levels caused by diseases of the adrenal gland (such as Addison's disease, adrenocortical insufficiency). Hydrocortisone belongs to a class of drugs known as corticosteroids. Corticosteroids are needed in many ways for the body to function well. They are important for salt and water balance and keeping blood pressure normal.

Lantus Solostar

Generic Formulation: Insulin Glargine,hum.Rec.AnlogSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 28
30-Day Fills 41.1
Days Supply 1,218
PA State Average Benchmarks
Peer Average Claims41.0
Peer Average 30-Day Fills74.7
Peer Average Days Supply2,103
Conservative Utilization

This provider writes prescriptions for this formulation 31.7% less frequently than the standard regional baseline metric for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $13,294.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$474.81

State Avg Cost Per Claim

$552.83

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS.

Therapeutic Applications

Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-yfgn.

Novolog Flexpen

Generic Formulation: Insulin AspartSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 13
30-Day Fills 20.3
Days Supply 609
PA State Average Benchmarks
Peer Average Claims37.0
Peer Average 30-Day Fills62.5
Peer Average Days Supply1,729
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 64.9% less volume than the regional standard for practitioners inside PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,938.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$687.59

State Avg Cost Per Claim

$898.23

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain.

Therapeutic Applications

Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product.

Ultra-Fine Mini Pen Needle

Generic Formulation: Pen Needle, DiabeticSpecialty: Nurse Practitioner
Provider Metrics Summary
Total Claims 18
30-Day Fills 18.7
Days Supply 460
PA State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills41.8
Peer Average Days Supply1,228
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across PA. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $928.58 across this reporting matrix range.

Provider Avg Cost Per Claim

$51.59

State Avg Cost Per Claim

$81.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like MS. AMANDA ELIZABETH HERSHEY CRNP provides transparency into local medical care patterns within Mechanicsburg, PA.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Psychiatric/Mental Health** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.